121 related articles for article (PubMed ID: 4881072)
21. [Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months].
Tidjani O; Grunitzky B; Guérin N; Lévy-Bruhl D; Lecam N; Xuereff C; Tatagan K
Bull Soc Pathol Exot; 1991; 84(5 Pt 5):873-84. PubMed ID: 1819435
[TBL] [Abstract][Full Text] [Related]
22. [Results of the use of the Leningrad-4 live measles vaccine during increasing measles morbidity].
Revenok ND; Smorodintsev AA
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():361-71. PubMed ID: 5860954
[No Abstract] [Full Text] [Related]
23. Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.
Cutts FT; Monteiro O; Tabard P; Cliff J
Bull World Health Organ; 1994; 72(2):227-31. PubMed ID: 8205642
[TBL] [Abstract][Full Text] [Related]
24. Lack of efficacy of the standard potency Edmonston-Zagreb live, attenuated measles vaccine in African infants.
Kiepiela P; Coovadia HM; Loening WE; Coward P; Botha G; Hugo J; Becker PJ
Bull World Health Organ; 1991; 69(2):221-7. PubMed ID: 1860150
[TBL] [Abstract][Full Text] [Related]
25. [Epidemiological effectiveness of the Leningrad-4 live measles vaccine of the Pasteur Institute of Epidemiology and Microbiology in Leningrad in children's centers].
Revenok ND; Groĭsman GM; Grozman IaG
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():346-54. PubMed ID: 5860952
[No Abstract] [Full Text] [Related]
26. [Immuno-epidemiologic considerations on the prevention of measles in Mexico].
Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R
Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412
[TBL] [Abstract][Full Text] [Related]
27. Trial of a reduced dose of measles vaccine in Nigerian children.
Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
[TBL] [Abstract][Full Text] [Related]
28. [Epidemiological investigations on measles in unvaccinated and vaccinated children (author's transl)].
Wiedermann G; Ambrosch F
Wien Klin Wochenschr; 1976 Sep; 88(17):545-54. PubMed ID: 997537
[TBL] [Abstract][Full Text] [Related]
29. Live measles vaccine prepared in dog kidney cells. 3. Vaccination against measles with Czechoslovak live vaccine.
Adam E; Kratochvílova M; Mares I; Drevo M; Závadová H
J Hyg Epidemiol Microbiol Immunol; 1966; 10(2):232-9. PubMed ID: 5330077
[No Abstract] [Full Text] [Related]
30. [High-potency live attenuated measles virus vaccine. Clinical results of Schwarz vaccine].
Fujii Y; Minamitani M; Nakamura K; Shinozaki T; Nagahama H
Nihon Ishikai Zasshi; 1969 Mar; 61(5):595-601. PubMed ID: 4890864
[No Abstract] [Full Text] [Related]
31. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
Dilraj A; Sukhoo R; Cutts FT; Bennett JV
Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
[TBL] [Abstract][Full Text] [Related]
32. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
[TBL] [Abstract][Full Text] [Related]
33. Combination of attenuated measles vaccine (Schwarz) with meningococcus A and A + C vaccine.
Ajjan N; Fayet MT; Biron G; Charbonnier C; Nicolas A; Triau R; Roumiantzeff M
Dev Biol Stand; 1978; 41():209-16. PubMed ID: 111980
[TBL] [Abstract][Full Text] [Related]
34. [Result of the study on reactogenic properties of the Leningrad-4 live measles vaccine in Leningrad].
Nikitin MIa; Kozlova NA; Kulikova VA; Malafeeva LK; Petrova TN
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():131-9. PubMed ID: 5863067
[No Abstract] [Full Text] [Related]
35. Immune responses to measles immunization and the impacts on HIV-infected children.
Thaithumyanon P; Punnahitananda S; Thisyakorn U; Praisuwanna P; Ruxrungtham K
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):658-62. PubMed ID: 11414407
[TBL] [Abstract][Full Text] [Related]
36. [Comparative value of 3 anti-measles vaccines with attenuated live virus. Immuno-epidemiological study].
Topciu V; Arion R; Moldovan E; Csaky N; Olaru G
Arch Roum Pathol Exp Microbiol; 1971 Mar; 30(1):119-27. PubMed ID: 5096857
[No Abstract] [Full Text] [Related]
37. [The clinico-immunological evaluation of a bivalent vaccine against measles and rubella].
Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
Minerva Pediatr; 1990 Dec; 42(12):531-6. PubMed ID: 2087226
[TBL] [Abstract][Full Text] [Related]
38. [Studies on the epidemiological effectiveness in Kirghizia of a live measles vaccine prepared from the Leningrad-4 strain].
Aminova MG; Cheredova NG; Novokreshchenova FA; Atakhanov KA; Aĭdaraliev KhA; Asankhodzhoev DD
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():335-45. PubMed ID: 4221934
[No Abstract] [Full Text] [Related]
39. [Results of the use of a live measles vaccine prepared from the Leningrad-16 strain].
Taros LIu; Boĭchuk LM; Smorodintsev AA
Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():57-77. PubMed ID: 5860963
[No Abstract] [Full Text] [Related]
40. [Comparative studies of measles vaccines prepared from further attenuated strains Schwarz and SEVAC].
Adam E; Fosenbauerová E; Domorázková E; Kratochvílová M; Kubátová E; Mares I; Drevo M; Svandová E
Cesk Pediatr; 1968 Jul; 23(7):581-93. PubMed ID: 5681931
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
